ID1 and hepatocellular carcinoma: In our recent study, we demonstrated that elevated BMP9 expression is associated with poorer HCC prognosis and that BMP9 promotes EpCAM-positive cancer stem cell properties in HCC by inhibiting DNA-binding protein 1 (ID1) [9].